JMAC Enterprises’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$666K Buy
27,652
+6
+0% +$157 0.11% 83
2026
Q1
$776K Buy
27,646
+3,005
+12% +$80K 0.15% 75
2025
Q4
$614K Buy
24,641
+7,638
+45% +$193K 0.12% 81
2025
Q3
$433K Buy
17,003
+5,131
+43% +$127K 0.09% 94
2025
Q2
$288K Sell
11,872
-4,042
-25% -$94.3K 0.06% 106
2025
Q1
$403K Sell
15,914
-20,239
-56% -$530K 0.1% 94
2024
Q4
$959K Sell
36,153
-11,313
-24% -$307K 0.15% 102
2024
Q3
$1.37M Sell
47,466
-1,038
-2% -$30.3K 0.22% 87
2024
Q2
$1.36M Buy
48,504
+1,641
+4% +$45.2K 0.24% 86
2024
Q1
$1.3M Sell
46,863
-3,808
-8% -$106K 0.24% 82
2023
Q4
$1.46M Sell
50,671
-13,080
-21% -$395K 0.31% 80
2023
Q3
$2.11M Sell
63,751
-404
-0.6% -$14.3K 0.52% 61
2023
Q2
$2.35M Buy
64,155
+3,714
+6% +$145K 0.58% 50
2023
Q1
$2.47M Buy
60,441
+13,161
+28% +$568K 0.63% 47
2022
Q4
$2.42M Buy
47,280
+1,699
+4% +$81.5K 0.67% 43
2022
Q3
$1.99M Buy
45,581
+192
+0.4% +$9.33K 0.56% 51
2022
Q2
$2.38M Buy
45,389
+377
+0.8% +$19.2K 0.61% 45
2022
Q1
$2.33M Sell
45,012
-405
-0.9% -$21K 0.55% 46
2021
Q4
$2.32M Buy
+45,417
New +$2.25M 0.55% 49

Other funds holding PFE

JMAC Enterprises's PFE Position: Q2 2026 in Review

JMAC Enterprises increased its Pfizer (PFE) stake by 0.02% in Q2 2026, buying an estimated $157 and bringing the position to 27,652 shares worth $666K. The position accounts for 0.11% of the portfolio, ranked #83.

JMAC Enterprises first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.47M in Q1 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • JMAC Enterprises held 27,652 shares of Pfizer worth $666K as of Q2 2026.
  • JMAC Enterprises bought 6 Pfizer shares in Q2 2026, an estimated $157.
  • Pfizer made up 0.11% of JMAC Enterprises's portfolio in Q2 2026, its #83 holding.
  • JMAC Enterprises first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • JMAC Enterprises's Pfizer position peaked at $2.47M in Q1 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.